Coldstream Capital Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $850K | Sell |
1,585
-41
| -3% | -$22K | 0.01% | 470 |
|
2025
Q1 | $683K | Buy |
1,626
+147
| +10% | +$61.7K | 0.01% | 487 |
|
2024
Q4 | $612K | Sell |
1,479
-100
| -6% | -$41.4K | 0.01% | 521 |
|
2024
Q3 | $787K | Buy |
1,579
+115
| +8% | +$57.3K | 0.02% | 447 |
|
2024
Q2 | $713K | Buy |
1,464
+158
| +12% | +$77K | 0.02% | 418 |
|
2024
Q1 | $705K | Buy |
1,306
+39
| +3% | +$21.1K | 0.02% | 432 |
|
2023
Q4 | $703K | Buy |
1,267
+55
| +5% | +$30.5K | 0.02% | 379 |
|
2023
Q3 | $530K | Sell |
1,212
-70
| -5% | -$30.6K | 0.02% | 403 |
|
2023
Q2 | $644K | Sell |
1,282
-3
| -0.2% | -$1.51K | 0.02% | 364 |
|
2023
Q1 | $643K | Buy |
1,285
+39
| +3% | +$19.5K | 0.02% | 360 |
|
2022
Q4 | $508K | Buy |
+1,246
| New | +$508K | 0.02% | 422 |
|
2022
Q2 | $413K | Buy |
1,178
+321
| +37% | +$113K | 0.02% | 459 |
|
2022
Q1 | $469K | Buy |
857
+28
| +3% | +$15.3K | 0.02% | 410 |
|
2021
Q4 | $546K | Buy |
+829
| New | +$546K | 0.02% | 400 |
|
2021
Q3 | – | Sell |
-364
| Closed | -$230K | – | 473 |
|
2021
Q2 | $230K | Buy |
+364
| New | +$230K | 0.01% | 469 |
|
2019
Q1 | – | Sell |
-1,093
| Closed | -$203K | – | 334 |
|
2018
Q4 | $203K | Sell |
1,093
-37
| -3% | -$6.87K | 0.02% | 293 |
|
2018
Q3 | $282K | Hold |
1,130
| – | – | 0.03% | 277 |
|
2018
Q2 | $247K | Sell |
1,130
-178
| -14% | -$38.9K | 0.03% | 275 |
|
2018
Q1 | $251K | Buy |
+1,308
| New | +$251K | 0.03% | 259 |
|